Full-Time

Head of Commercial Operations

Confirmed live in the last 24 hours

Serán BioScience

Serán BioScience

51-200 employees

Contract development and manufacturing for pharmaceuticals

No salary listed

Expert

Bend, OR, USA

The Corporate Headquarters of Serán BioScience are located at 63047 Layton Ave, Bend, OR 97701. Domestic and international travel required.

Category
Generalist Operations
Supply Chain Management
Operations & Logistics
Requirements
  • Technical depth, including drug substance, drug product, and understanding of materials characteristics
  • Excellent verbal and written communication abilities, interpersonal and customer service skills
  • High degree of organizational skills and attention to detail
  • Excellent time management skills with a proven ability to meet deadlines
  • Strong analytical and problem-solving skills
  • Strong supervisory and leadership skills
  • Ability to prioritize tasks and to delegate them when appropriate
  • Ability to function well in a high-paced and at times stressful environment
  • Proficient with Microsoft Office Suite or related software
  • Demonstrates strong project management, customer relationship skills, and communication skills
  • Able to build strong and motivational relationships with executive management and operations teams
  • Able to develop and implement strategic business plans and commercialization strategies
  • BS in Life Science or Engineering discipline required, MS or Ph.D. preferred
  • Minimum of 10 years of experience in CDMO/CMO Commercial Operations
Responsibilities
  • Directs daily operations at Serán’s Commercial Manufacturing Facility
  • Ensures client projects are delivered on-time and executed to full compliance with global regulatory requirements and client agreements
  • Manages the introduction of new commercial projects
  • Acts as commercial representative for key customer relationships
  • Leads execution of the commercial and business strategy in development and manufacturing
  • Provides commercial input for facility and capital improvements, including the construction of a greenfield commercial facility
  • Ensures that the health, safety, and environmental impact policies of the Serán sites are being successfully implemented
  • Provides strategic input to support business model and company growth
  • Supports customer site visits to facilitate onboarding of new customers and to maintain strong customer relationships
  • Develops and implements metrics for consistent improvement of Commercial Operations and compliance
  • Optimizes processes to reduce manufacturing costs and maximize cGMP production throughput
  • Represents commercial team during budget planning meetings
  • Responsible for management of pipeline / portfolio and delivery of products
  • Manages the manufacturing operations technical team and production teams
  • Meets frequently with quality, project management, and executive management teams
  • Performs other related duties as assigned
Desired Qualifications
  • Preference given to those with direct experience in development and manufacturing of spray drying technologies
  • Extensive knowledge of multiple technologies (Drug Substance, Drug Product, Development, and manufacturing service lines)

Serán BioScience specializes in providing drug development and manufacturing services as a Contract Development and Manufacturing Organization (CDMO). They offer a variety of services including preformulation, formulation development, dosage form development, spray drying, and particle engineering. Their operations adhere to current Good Manufacturing Practice (cGMP) standards, ensuring high quality and safety in their products through rigorous analytical quality control. Serán BioScience caters to a wide range of clients, from small biotech startups to large pharmaceutical companies, and is recognized for its flexibility in tailoring services to meet specific client needs. The company's goal is to enhance the efficiency and effectiveness of drug development processes for their clients, leveraging advanced technology and scientific expertise.

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

$200M

Headquarters

Bend, Oregon

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Serán announced a $200 million strategic growth transaction for expansion.
  • The company plans to build a new commercial-scale manufacturing facility.
  • Increased demand for personalized medicine aligns with Serán's formulation expertise.

What critics are saying

  • Emerging CDMOs in Asia offer lower-cost services, impacting Serán's market share.
  • Potential delays in new facility construction could affect expansion plans.
  • Global talent shortage may hinder recruitment for Serán's expansion.

What makes Serán BioScience unique

  • Serán specializes in advanced drug formulation techniques, including spray drying and particle engineering.
  • The company offers cGMP manufacturing and analytical quality control services.
  • Serán's flexibility allows tailored services to meet specific client needs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

Health Insurance

Life Insurance

Disability Insurance

Mental Health Support

Pet Insurance

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

17%

2 year growth

17%
Bain Capital
Nov 18th, 2024
Serán Bioscience Announces $200 Million Strategic Growth Transaction and Plans for New Commercial Facility

Serán Bioscience announces $200 million strategic growth transaction and plans for new commercial facility.

TechMub
Sep 17th, 2024
Serán Bioscience Raises $200M for Strategic Expansion and New Commercial Facility

With over 200 team members, including 150 scientists and engineers, Serán plans to add 150 more employees as part of its expansion.

Contract Pharma
Sep 17th, 2024
Serán Bioscience Plans New Commercial-Scale Manufacturing Facility

Serán Bioscience, a contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, analytical, and manufacturing services to pharmaceutical and biotechnology companies, has announced a strategic growth transaction of more than $200 million, which will support Serán's continued growth and construction of a new commercial-scale manufacturing facility.

BioSpace
Feb 7th, 2024
The Ira: A Catalyst For Societal Change

"Politics, Patients, and Pharma" Image Credit: Nicole Bean for BioSpaceWhen prescription drug benefits were added to Medicare via the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the government was not given the ability to negotiate drug pricing. As a result, pharmaceutical companies were, and are, able to determine their own pricing. Another result is that prices for prescription drugs are higher in the U.S., significantly higher, than in most other developed countries.In a 2021 study conducted by the RAND Corporation, researchers estimated that U.S. drug prices were an average 2.56 times higher than the other 32 countries in the Organization for Economic Co-operation and Development (OECD). The gap increases to 3.44 times higher for larger brand-name drugs.Balancing Innovation, Pricing PatientsBoth the government and the pharma industry seek to give patients access to medications that enhance their quality of life. The question is how to achieve this without putting financial burdens on these patients

Cascade Business News
Nov 9th, 2023
Serán Bioscience Breaks Ground on Additional cGMP Manufacturing Capacity at its Bend Site

Serán is partnering with Oregon Bioscience Association ( oregonbio.org ) to establish a state-sponsored apprenticeship program with the goal of providing paid employment and education to entry-level operations and laboratory technicians.